The effect of waiving consent on enrollment in a sepsis trial

1 February 2004

journal article
research article
Published by Springer Nature in Intensive Care Medicine

Vol. 30 (2) , 321-324
https://doi.org/10.1007/s00134-003-2065-8

Abstract

Illustration of the difficulties in approaching critically ill patients for informed consent for inclusion into a randomized controlled trial and the impact of a waiver of consent from the patient’s next of kin in the conduction of such studies.

Keywords

This publication has 7 references indexed in Scilit:

Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use.
2005
Efficacy of Recombinant Human Erythropoietin in Critically Ill Patients
JAMA, 2002
Corticosteroids and septic shock.
JAMA, 2002
Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock
JAMA, 2002
Safeguarding Patients in Clinical Trials with High Mortality Rates
American Journal of Respiratory and Critical Care Medicine, 2001
Is Informed Consent Always Necessary for Randomized, Controlled Trials?
New England Journal of Medicine, 1999
Evaluation of Institutional Review Board review and informed consent in publications of human research in critical care medicine
Critical Care Medicine, 1998